Metabotropic Glutamate Receptors and Cell-Type-Specific Vulnerability in the Striatum: Implication for Ischemia and Huntington's Disease
- 1 July 1999
- journal article
- Published by Elsevier BV in Experimental Neurology
- Vol. 158 (1), 97-108
- https://doi.org/10.1006/exnr.1999.7092
Abstract
No abstract availableThis publication has 74 references indexed in Scilit:
- Endogenous ACh enhances striatal NMDA‐responses via M1‐like muscarinic receptors and PKC activationEuropean Journal of Neuroscience, 1998
- Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: Implications for ischemia and Huntington's diseaseAnnals of Neurology, 1998
- Endogenous Adenosine Mediates the Presynaptic Inhibition Induced by Aglycemia at Corticostriatal SynapsesJournal of Neuroscience, 1997
- Opposite Membrane Potential Changes Induced by Glucose Deprivation in Striatal Spiny Neurons and in Large Aspiny InterneuronsJournal of Neuroscience, 1997
- Vulnerability of Medium Spiny Striatal Neurons to Glutamate: Role of Na+/K+ ATPaseEuropean Journal of Neuroscience, 1995
- Long-term synaptic depression in the striatum: physiological and pharmacological characterizationJournal of Neuroscience, 1992
- Signal transduction and pharmacological characteristics of a metabotropic glutamate receptor, mGluRl, in transfected CHO cellsNeuron, 1992
- Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?Annals of Neurology, 1992
- Kainic acid on neostriatal neurons intracellularly recorded in vitro: electrophysiological evidence for differential neuronal sensitivityJournal of Neuroscience, 1990
- Replication of the neurochemical characteristics of Huntington's disease by quinolinic acidNature, 1986